Medical/Pharmaceuticals

Alpro Pharmacy and OMRON Healthcare Unite to Combat Fake BP Monitors

Free Blood Pressure Monitor Accuracy Check Nationwide KUALA LUMPUR, Malaysia, Jan. 27, 2025 /PRNewswire/ -- Hypertension, or high blood pressure, affects 3 in 10 Malaysians, making it a prevalent health concern in the country (National Health and Morbidity Survey, 2019). Of the 3, only 2 are awa...

2025-01-27 08:00 5660

FDA Clears World's First Mobile App for Contactless Pulse Rate Measurement

* PanopticAI's tech turns smartphones and tablets into medical-grade vital sign monitors. * This is a major milestone in the Hong Kong-based startup's mission to ensure accessible, scalable healthcare. * The AI-based technology's diverse use cases include telehealth, remote patient monitori...

2025-01-26 10:00 9271

X4 Pharmaceuticals Announces EMA Validation of Marketing Authorization Application (MAA) for Mavorixafor - licenced to Norgine for commercialisation in Europe.

LONDON, Jan. 25, 2025 /PRNewswire/ -- Following the licensing agreement with X4 Pharmaceuticals, Norgine is pleased to see the announcement from X4 today that their Marketing Authorization Application (MAA) for mavorixafor for the treatment of WHIM syndrome (warts, hypogammaglobulinemia, infectio...

2025-01-25 02:00 6872

Winter Davos 2025: Yidu Tech Accelerates Global Expansion of AI-Powered Healthcare Solutions

DAVOS, Switzerland, Jan. 24, 2025 /PRNewswire/ -- From January 20 to 24, the World Economic Forum Annual Meeting 2025, also known asWinter Davos, gathered global leaders inDavos, Switzerland. Representing China's AI-powered healthcare sector, Ms. Gong Rujing(Yingying), Founder and Chairwoman of Y...

2025-01-24 21:47 7456

Sino Group and the Ng Teng Fong Charitable Foundation Launch 'Community Care Chinese Medicine Service' with Hong Kong Baptist University to Support the Well-Being of the Underprivileged

HONG KONG, Jan. 24, 2025 /PRNewswire/ -- Sino Group (the 'Group'), the Ng Teng Fong Charitable Foundation ('NTFCF'), and the School of Chinese Medicine at Hong KongBaptist University ('HKBU') are committed to the well-being of underprivileged members of the community and have recently launched th...

2025-01-24 21:27 10440

Professor Tinly Wong Tin-Chee Pre- and Post-Exercise Care Tips from a Traditional Chinese Medicine Perspective

HONG KONG, Jan. 24, 2025 /PRNewswire/ -- The annual Hong Kong Marathon is just around the corner, and runners are actively preparing. In addition to physical training, proper warm-ups before the race and recovery after are equally important. Professor Tinly Wong Tin-Chee, founder of Herbalgy Phar...

2025-01-24 18:00 4790

Accuray Announces First 100 Patient Treatment Regimens Completed in China Using the Tomo® C Radiation Treatment Delivery System, a CNNC-Accuray Joint Venture Product

MADISON, Wis., Jan. 23, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that Shandong Cancer Hospital and Institute has achieved a milestone with the completion of treatment for 100 patients using the Tomo® C Radiation Treatment Delivery System, a product built inChina th...

2025-01-23 20:35 4581

European Wellness Biomedical Group (EWBG) Partners with Toviyah Life to Unveil Cutting-Edge Health Technology

KOTA KINABALU, Malaysia, Jan. 23, 2025 /PRNewswire/ -- The European Wellness Biomedical Group (EWBG) and Toviyah Life Pte Ltd (Toviyah) have announced a new partnership aimed at improving wellness through a handheld device called BeLight. The two companies signed a Memorandum of Understanding (MO...

2025-01-23 16:45 7538

Kelun-Biotech's Product Tagitanlimab Approved for Marketing in Second Indication in Combination with Cisplatin and Gemcitabine For the First-line Treatment of Patients with recurrent or metastatic NPC

CHENGDU, China, Jan. 23, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that the Company received marketing authorization inChina from National Medical Products Administration (NMPA) for the programmed cell death ligand 1(PD-L1)-directed innovativ...

2025-01-23 13:44 4066

GC Cell Symposium with Bifarma Expands Global Impact and Reach for Immuncell-LC

YONGIN, South Korea, Jan. 23, 2025 /PRNewswire/ -- GC Cell , a leading cell and gene therapy company, announced the successful completion of its first thought leadership symposium in Jakarta, Indonesia. The event was organized in collaboration with PT Bifarma Ad...

2025-01-23 09:30 3451

Sunway Medical Centre named in the inaugural Newsweek's Asia's Top Private Hospitals 2025 ranking

SUBANG JAYA, Malaysia, Jan. 23, 2025 /PRNewswire/ -- Sunway Medical Centre, Sunway City (SMC), has been honoured in the inaugural Newsweek's Top Private Hospitals 2025ranking and recognised as the top hospital in Malaysia for four out of five procedures: knee surgery and knee replacement, shoulde...

2025-01-23 07:28 4905

deCODE genetics: Complete recombination map of the human-genome, a major step in genetics

REYKJAVIK, Iceland, Jan. 23, 2025 /PRNewswire/ -- Scientists at deCODE genetics/Amgen have constructed a complete map of how human DNA is mixed as it is passed down during reproduction. The map marks a major step in the understanding of genetic diversity and its impact on health and fertility. It...

2025-01-23 00:00 4878

Forum 30: Advancing Global Standards for Medical Products of Human Origin

REDLANDS, Calif., Jan. 22, 2025 /PRNewswire/ -- The International Council for Commonality in Blood Banking Automation ("ICCBBA"), in partnership with the Italian national competent authority for bloodCentro Nazionale Sangue ("CNS") and for cells/tissuesCentro Nazionale Trapianti ("CNT"), hosted F...

2025-01-22 23:54 2830

TraceLink Named to the 2025 RXinsider Pharmacy500 List for Excellence in Pharmacy Supply Chain Innovation

TraceLink recognized for advancing digitalization and orchestration in the pharmacy supply chain, ensuring safe and timely access to medications BOSTON, Jan. 22, 2025 /PRNewswire/ -- TraceLink, the largest end-to-end digital network platform for intelligent supply chain orchestration, is honored ...

2025-01-22 23:00 3329

JelloX Aims to Improve Patient-Centered Care with AI-powered 3D Digital Pathology

First shared at a recent Japanese Society of Digital Pathology meeting, the company is forging a global alliance with a leading US medical institution and other organizations to harness technology for better patient care and outcomes in oncology. TAIPEI, Jan. 22, 2025 /PRNewswire/ -- JelloX

2025-01-22 15:29 4423

Science and Technology Daily: AI for a Better Life

BEIJING, Jan. 22, 2025 /PRNewswire/ -- As AI continues to evolve at an unprecedented pace, with breakthroughs in generative models, ethical guidelines, and applications across various sectors, the question is often asked — how will these advancements positively impact people's daily life?   Sci...

2025-01-22 12:20 3619

Lepu Biopharma has granted ArriVent Exclusive License for MRG007, a Potential Best-in-Class ADC for the treatment of Gastrointestinal Cancers

HONG KONG, Jan. 22, 2025 /PRNewswire/ -- Today, Lepu Biopharma Co., Ltd (Stock Code: 02157.HK) announced that it has entered into an exclusive licensing agreement withArriVent BioPharma, Inc. for MRG007, a Potential Best-in-Class antibody- drug conjugate ("ADC") for the treatment of Gastrointesti...

2025-01-22 12:19 5367

Thailand to Showcase Medical and Wellness Excellence at Expo 2025 Osaka, Kansai, Japan

BANGKOK, Jan. 22, 2025 /PRNewswire/ -- Thailand is set to make a grand debut at Expo 2025 Osaka, Kansai,Japan, highlighting the country's commitment to becoming one of the global leaders in medical and wellness services. In line with the Expo's theme"Designing Future Society for Our Lives," Thail...

2025-01-22 10:30 7249

Ascletis Announces Positive Results from U.S. Phase Ia Single Ascending Dose Study of Small Molecule Oral GLP-1R Agonist ASC30 and Provides Program Update

* ASC30 oral tablet demonstrated dose-proportional pharmacokinetic (PK) properties and a long half-life (t1/2) up to 60 hours in the single ascending dose (SAD) study of patients with obesity, supporting once-daily or less frequent oral dosing. * ASC30 oral tablet was generally safe and well ...

2025-01-21 19:00 6053

MedAdvisor Solutions' helps pharmacists in Australia deliver more than 115,000 clinical services to patients through Expanded Scope of Practice Pilots in 2024

New case study showcases improved operational efficiency and patient care with enhanced workflow and clinical services for pharmacists MELBOURNE, Australia, Jan. 21, 2025 /PRNewswire/ -- MedAdvisor Solutions, a global leader in patient engagement and pharmacy technology, published its newest cas...

2025-01-21 07:22 3127
1 ... 122123124125126127128 ... 381